Orthotopic liver transplantation for preoperative XXXX .

@entity1 @entity66 @entity5 @entity160 @entity157 @entity99
OBJECTIVE: To report our experience with orthotopic liver transplantation (OLT) for highly selected @entity1 with @entity5 ( @entity157 ). DESIGN: We retrospectively analyzed the demographic, clinical, pathologic, and survival data on 21 @entity1 with @entity157 who underwent OLT at the Mayo Clinic between 1985 and 1993. MATERIAL AND METHODS: The 21 @entity1 were categorized into three groups: (1) those with incidental @entity157 (no evidence of @entity157 preoperatively), (2) those with a @entity99 without vascular invasion, and (3) those with an increased serum @entity160 ( @entity160 ) concentration but no detectable @entity66 in the liver. RESULTS: For the seven @entity1 with incidental @entity157 , the 2-year disease-free survival was 68.5%. For the eight @entity1 with a @entity66 , the 2-year disease-free survival was only 50%. Operative staging revealed more advanced stage disease than had been found on preoperative assessment in five of these eight @entity1 . For the six @entity1 with an increased serum @entity160 value but no @entity66 , the 2-year disease-free survival was 80%. @entity5 recurrence was the major cause of all deaths in this series. CONCLUSION: Disease-free survival for @entity1 with radiographic early-stage @entity157 was suboptimal because of understaging of the disease preoperatively. In contrast, our initial experience with OLT for @entity1 with an increased serum @entity160 value in the absence of a @entity66 in the liver was favorable.
